Novo Nordisk has announced its adoption of Anthropic's Claude AI model to expedite drug discovery and software development processes. The company's CEO stated that this integration aims to "supercharge R&D" efforts, leveraging AI for faster innovation in pharmaceuticals. AI
IMPACT Accelerates pharmaceutical R&D cycles by integrating advanced AI capabilities for drug discovery and software development.
RANK_REASON Company announces integration of an existing AI model into its R&D processes.
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →